SCHEMBL14653586

SCHEMBL14653586

Nc1ccc2ncc(-c3cccc(OC(F)(F)F)c3)n2n1

nearest known ligand 0.73

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 12/20 0.73
PIM1 P11309 8/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15699138 0.88 DYRK1A (0.76) DYRK1APIM1
SCHEMBL102421 0.86 DYRK1A (0.91) DYRK1APIM1
SCHEMBL29436156 0.85 DYRK1A (0.73) DYRK1APIM1
SCHEMBL102330 0.85 DYRK1A (0.73) DYRK1APIM1
SCHEMBL26745373 0.84 DYRK1A (1.00) DYRK1APIM1
Sulfuric Acid SCHEMBL30631762 0.84 DYRK1A (0.53) DYRK1APIM1
SCHEMBL19987042 0.82 PIM1 (0.76) DYRK1APIM1
SCHEMBL24333076 0.81 DYRK1A (1.00) DYRK1A
SCHEMBL13867672 0.81 PIM1 (0.77) DYRK1APIM1
SCHEMBL14653658 0.81 DYRK1A (0.74) DYRK1APIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3812387-A1 HETEROCYCLIC PROTEIN KINASE INHIBITORS Sumitomo Dainippon Pharma Oncology, Inc. (US) 2021-04-28 EP disclosed
EP-3409278-B1 HETEROCYCLIC PROTEIN KINASE INHIBITORS TOLERO PHARMACEUTICALS INC (US) 2020-09-16 EP disclosed
EP-2734205-B1 HETEROCYCLIC PROTEIN KINASE INHIBITORS TOLERO PHARMACEUTICALS INC (US) 2018-03-21 EP disclosed
WO-2013013188-A1 HETEROCYCLIC PROTEIN KINASE INHIBITORS TOLERO PHARMACEUTICALS, INC. (US) 2013-01-24 WO disclosed